Welcome to BioNome, Subsidiary of SRNOME Pvt Ltd

Category: blogs

Role of miRNA & siRNA in Cancer Genomics: Insights from NGS Data in Bangalore

Cancer genomics has transformed our understanding of tumor biology, enabling researchers to explore genetic and epigenetic changes driving disease progression. Among the most critical regulatory molecules in cancer research are microRNAs (miRNAs) and small interfering RNAs (siRNAs). In Bangalore’s rapidly expanding biotech and genomics ecosystem, Next-Generation Sequencing (NGS) plays a pivotal role in uncovering the regulatory impact of these small RNAs in cancer development and therapy.miRNA in Cancer GenomicsmiRNAs are short non-coding RNAs that regulate gene expression by binding to messenger RNAs (mRNAs). In cancer, certain miRNAs function as:OncomiRs (oncogenic miRNAs) that promote tumor growthTumor suppressor miRNAs that inhibit cancer progressionDifferential expression analysis using small RNA-Seq helps identify miRNAs that are significantly upregulated or downregulated in tumor samples compared to healthy tissues. These miRNAs can serve as:Diagnostic biomarkersPrognostic indicatorsTherapeutic targetssiRNA in Cancer ResearchsiRNAs are widely used in cancer genomics for gene silencing and functional validation studies. By selectively knocking down oncogenes or cancer-associated genes, researchers can better understand tumor pathways and evaluate potential drug targets.NGS-based siRNA identification and profiling help:Validate gene targets in oncologyStudy RNA interference mechanismsAssess off-target effectsSupport RNA-based therapeutic developmentInsights from NGS DataAdvanced NGS workflows allow researchers in Bangalore to perform:Quality control and preprocessing of small RNA dataAlignment to reference genomes and miRNA databasesNovel miRNA discoveryDifferential expression analysisTarget gene prediction and pathway enrichmentThese bioinformatics analyses provide deep insights into molecular pathways driving cancer progression.Why Choose BioNomeRecognized as the Best Bioinformatics Service Provider in Hennur (Karnataka), BioNome offers affordable bioinformatics services for cancer genomics research.Our expertise includes:miRNA & siRNA identification from NGS dataDifferential expression analysisTarget prediction and functional annotationPathway enrichment and regulatory network analysisEnd-to-end small RNA-Seq and transcriptomics solutionsWith advanced computational infrastructure and experienced bioinformaticians, BioNome supports pharmaceutical companies, biotech startups, hospitals, and academic researchers in Bangalore.Contact BioNome📞 Phone: +91 8668470445📧 Email: info@bionome.inAccelerate your cancer genomics research in Bangalore with expert miRNA & siRNA NGS analysis services from BioNome, delivering accurate, affordable, and insight-driven bioinformatics solutions.

Read More

siRNA Identification for Gene Silencing & Therapeutic Research in India

Small interfering RNAs (siRNAs) have revolutionized modern molecular biology by enabling precise gene silencing through RNA interference (RNAi). In India’s rapidly growing biotechnology, genomics, and pharmaceutical sectors, siRNA identification using Next-Generation Sequencing (NGS) data analysis plays a vital role in functional genomics studies and therapeutic development.What is siRNA and Why is it Important?siRNAs are short double-stranded RNA molecules, typically 20–25 nucleotides long, that bind to complementary messenger RNA (mRNA) sequences and trigger their degradation. This process effectively “switches off” specific genes, making siRNAs powerful tools for:Functional genomics researchTarget validation in drug discoveryCancer and viral disease researchDevelopment of RNA-based therapeuticsPrecision medicine approachesAccurate identification and analysis of siRNA sequences are critical for designing effective gene-silencing strategies.Role of NGS in siRNA IdentificationNGS-based small RNA sequencing enables high-throughput detection and quantification of siRNAs. A robust bioinformatics pipeline typically includes:Quality control and adapter trimmingAlignment to reference genomeIdentification of siRNA clustersExpression profiling across samplesOff-target prediction analysisFunctional annotation and pathway enrichmentThese computational steps ensure accurate detection while minimizing false positives and unintended off-target effects.Importance for Therapeutic Research in IndiaIndia is advancing rapidly in RNA therapeutics, cancer research, and antiviral drug development. siRNA identification supports:Validation of disease-associated genesDevelopment of targeted gene therapiesIdentification of novel therapeutic targetsDesign of safer and more efficient RNA-based drugsBy integrating siRNA analysis with transcriptomics and differential gene expression studies, researchers can build a comprehensive understanding of gene regulation networks.Why Choose BioNomeRecognized as the Best Bioinformatics Service Provider in Bangalore (Karnataka), BioNome provides affordable bioinformatics services for advanced NGS data analysis.Our services include:siRNA identification and expression analysismiRNA and small RNA-Seq analysisOff-target and target prediction studiesFunctional annotation and pathway analysisEnd-to-end genomics and transcriptomics solutionsWith advanced computational tools and experienced bioinformaticians, BioNome ensures accurate, reproducible, and research-ready results for pharmaceutical companies, biotech startups, and academic institutions across India.Contact BioNome📞 Phone: +91 8668470445📧 Email: info@bionome.inAccelerate your gene silencing and therapeutic research in India with expert siRNA identification services from BioNome, delivering precise, affordable, and high-quality NGS data analysis solutions.

Read More

Differential Expression Analysis of miRNA in Disease Research in India

MicroRNAs (miRNAs) are powerful regulators of gene expression and play a crucial role in the development and progression of many diseases, including cancer, cardiovascular disorders, diabetes, and neurological conditions. In India’s rapidly growing genomics and precision medicine landscape, Differential Expression Analysis of miRNA using NGS data has become an essential approach for understanding disease mechanisms and identifying potential biomarkers.What is Differential Expression Analysis of miRNA?Differential expression analysis compares miRNA expression levels between two or more biological conditions, such as:Healthy vs diseased samplesTreated vs untreated groupsEarly-stage vs advanced disease conditionsUsing small RNA sequencing (small RNA-Seq), researchers can quantify miRNA expression levels across samples. Bioinformatics pipelines then apply statistical models to identify significantly upregulated or downregulated miRNAs. These differentially expressed miRNAs often serve as potential biomarkers or therapeutic targets.Importance in Disease ResearchDifferential miRNA profiling supports:Early disease detection and diagnosisPrognostic biomarker identificationUnderstanding molecular pathways involved in disease progressionDrug target validationDevelopment of RNA-based therapeuticsFor example, specific miRNAs are known to regulate oncogenes and tumor suppressor genes in cancer research. Identifying altered miRNA expression patterns can reveal key regulatory networks driving disease.Bioinformatics WorkflowAccurate differential expression analysis involves several critical steps:Quality control and adapter trimming of NGS dataAlignment to reference genome and miRNA databasesNormalization of read countsStatistical testing for significant expression changesTarget gene prediction and pathway enrichment analysisReliable computational analysis is essential to minimize false positives and ensure reproducible results.Why Choose BioNomeRecognized as the Best Bioinformatics Service Provider in Bangalore (Karnataka), BioNome offers affordable bioinformatics services for comprehensive NGS and small RNA-Seq analysis.Our services include:miRNA differential expression analysisKnown and novel miRNA identificationTarget gene prediction and functional annotationPathway enrichment and regulatory network analysisEnd-to-end transcriptomics and genomics data interpretationWith advanced computational infrastructure and experienced bioinformaticians, BioNome delivers accurate and research-ready insights for pharmaceutical companies, biotech startups, hospitals, and academic institutions across India.Contact BioNome📞 Phone: +91 8668470445📧 Email: info@bionome.inEnhance your disease research in India with expert miRNA Differential Expression Analysis services from BioNome, providing precise, affordable, and high-quality NGS data analysis solutions.

Read More

Known vs Novel miRNA Discovery Using NGS Data in India

MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression and play critical roles in cancer biology, cardiovascular disorders, neurological diseases, and immune responses. With the advancement of Next-Generation Sequencing (NGS), researchers in India can now identify both known and novel miRNAs with high sensitivity and accuracy. Understanding the difference between known and novel miRNA discovery is essential for effective genomics and transcriptomics research.What is Known miRNA Identification?Known miRNA identification involves detecting previously characterized miRNAs that are already documented in public databases such as miRBase. During NGS data analysis, small RNA reads are aligned to reference genomes and compared against curated miRNA databases.This approach helps in:Quantifying expression levels of established miRNAsPerforming differential expression analysisIdentifying disease-associated biomarkersSupporting drug target validationKnown miRNA profiling is especially valuable in clinical research and biomarker discovery studies.What is Novel miRNA Discovery?Novel miRNA discovery focuses on identifying previously unreported miRNA sequences from NGS datasets. This requires advanced computational analysis, including:Prediction of hairpin precursor structuresSecondary structure stability assessmentRead distribution pattern evaluationFiltering false positivesNovel miRNA discovery expands the understanding of gene regulation and can uncover new therapeutic targets. In India’s growing precision medicine and RNA therapeutics sector, identifying novel regulatory RNAs is becoming increasingly important.Importance for Indian Genomics ResearchIndia is rapidly advancing in genomics, RNA-Seq analysis, and personalized medicine. Combining known and novel miRNA discovery provides:Comprehensive transcriptome insightsBetter understanding of disease mechanismsIdentification of new biomarkersStronger foundation for RNA-based drug developmentAccurate computational pipelines are crucial to ensure reliable and reproducible results.Why Choose BioNomeRecognized as the Best Bioinformatics Service Provider in Bangalore (Karnataka), BioNome offers affordable bioinformatics services for:miRNA and siRNA identificationSmall RNA-Seq analysisDifferential expression studiesTarget gene prediction and pathway enrichmentEnd-to-end NGS data analysisOur experienced team ensures high-quality data processing, precise analysis, and detailed reporting tailored to research needs.Contact BioNome📞 Phone: +91 8668470445📧 Email: info@bionome.inAdvance your genomics research in India with expert Known and Novel miRNA Discovery services from BioNome, delivering accurate, affordable, and insight-driven NGS data analysis solutions.

Read More